natgillin/translations-raw huggingface dataset:
Unge mennesker i alderen 13 år og derover fik bivirkninger, der var sammenlignelige i hyppighed og type af bivirkninger hos voksne, undtagen for træthed, ukontrollerbare, spjættende eller rykkende bevægelser, rastløshed og træthed, der blev observeret med hyppigheden ”meget almindelig” (kan forekomme hos flere end 1 ud af 10 patienter), og mavesmerter i den øverste del af maven, tør mund, øget hjerterytme (puls), vægtstigning, øget appetit, muskeltrækninger, ukontrollerede bevægelser af arme og ben samt svimmelhed, specielt ved skift fra liggende eller siddende til oprejst stilling, hvor hyppigheden var ”almindelig” (flere end 1 ud af 100 patienter).
Additional side effects in children and adolescents Adolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepiness, uncontrollable twitching or jerking movements, restlessness, and tiredness were very common (may affect more than 1 in 10 people) and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle twitching, uncontrolled movements of the limbs, and feeling dizzy, especially when getting up from a lying or sitting position, were common (may affect up to 1 in 10 people).
4.2) Aripiprazol blev undersøgt hos patienter i aldersgruppen 6 til 17 år i to 8-ugers, placebokontrollerede forsøg [én fleksibel dosis (2 - 15 mg/dag) og én fast dosis (5, 10 eller 15 mg/dag)] og i et 52-ugers åbent forsøg.
Irritability associated with autistic disorder in paediatric patients (see section 4.2) Aripiprazole was studied in patients aged 6 to 17 years in two 8-week, placebo-controlled trials [one flexible-dose (2 - 15 mg/day) and one fixed-dose (5, 10, or 15 mg/day)] and in one 52-week openlabel trial.
Forekomsten af hyperprolaktinæmi eller forhøjet serumprolaktin i aripiprazol-gruppen (0,3 %) svarede til forekomsten i placebo-gruppen (0,2 %).
The incidence of hyperprolactinaemia or increased serum prolactin in patients treated with aripiprazole (0.3%) was similar to that of placebo (0.2%).
Dosisjustering til patienter med let til moderat leverinsufficiens er ikke påkrævet.
No dosage adjustment is required for patients with mild to moderate hepatic impairment.
Pakningsstørrelser: 14, 28, 49, 56 eller 98 tabletter.
Pack size: 14, 28, 49, 56, or 98 tablets
• livstruende uregelmæssig hjerterytme,
• life-threatening irregular heart beat,
Hvis du holder op med at tage Aripiprazole Zentiva
If you stop taking Aripiprazole Zentiva
Aripiprazole Zentiva indeholder sodium
Aripiprazole Zentiva contains sodium
Derfor frarådes Aripiprazole Zentiva til patienter under 13 år (se pkt.
Therefore, Aripiprazole Zentiva is not recommended for use in patients below 13 years of age (see sections 4.8 and 5.1).
Psykiske forstyrrelser Søvnløshed
Psychiatric disorders Insomnia Anxiety
Almindelig Ikke almindelig Ikke kendt
Not known
Hvis du har glemt at tage Aripiprazole Zentiva
If you forget to take Aripiprazole Zentiva
Skizofreni: Den anbefalede startdosis for Aripiprazole Zentiva er 10 eller 15 mg/dag med en vedligeholdelsesdosis på 15 mg/dag, administreret som en enkelt daglig dosis uden hensyntagen til måltider.
The recommended starting dose for Aripiprazole Zentiva is 10 or 15 mg/day with a maintenance dose of 15 mg/day administered on a once-a-day schedule without regard to meals.
Det skal du vide, før du begynder at tage Aripiprazole Zentiva Tag ikke Aripiprazole Zentiva
What you need to know before you take Aripiprazole Zentiva Do not take Aripiprazole Zentiva
I et korterevarende, placebo-kontrolleret klinisk forsøg, der involverede 302 unge (13 - 17 år) med skizofreni, var bivirkningsfrekvensen og -typen lig den for voksne undtagen for følgende bivirkninger, der blev rapporteret hyppigere hos unge, der fik aripiprazol end hos voksne, der fik aripiprazol (og hyppigere end med placebo): Døsighed/sedation og ekstrapyramidale forstyrrelser blev meget almindeligt rapporteret (≥ 1/10) og tør mund, øget appetit og ortostatisk hypotension blev almindeligt rapporteret (≥ 1/100 til < 1/10).
Schizophrenia in adolescents aged 15 years and older In a short-term placebo-controlled clinical trial involving 302 adolescents (13 - 17 years) with schizophrenia, the frequency and type of adverse reactions were similar to those in adults except for the following reactions that were reported more frequently in adolescents receiving aripiprazole than in adults receiving aripiprazole (and more frequently than placebo): Somnolence/sedation and extrapyramidal disorder were reported very commonly (≥ 1/10), and dry mouth, increased appetite, and orthostatic hypotension were reported commonly (≥ 1/100, < 1/10).
I et andet 12-ugers forsøg var forekomsten af EPS 26,6 % for aripiprazol-behandlede patienter og 17,6 % for lithium-behandlede patienter.
In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium.
Patienter som behandles med antipsykotika, herunder aripiprazol, bør observeres for symptomer for hyperglykæmi (fx polydipsi, polyuri, polyfagi og svækkelse), og patienter med diabetes mellitus, eller med risiko for at udvikle diabetes mellitus, bør monitoreres regelmæssigt med henblik på dårligere glucosekontrol (se pkt.
Patients treated with any antipsychotics, including aripiprazole, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control (see section 4.8).
Ved administration af aripiprazoldoser i intervallet 0,5-30 mg, én gang dagligt til raske personer i 2 uger, sås dosisafhængig reduktion i bindingen af 11C-racloprid, en D2/D3-receptorligand til caudatus og putamen påvist ved positronemissionstomografi.
Aripiprazole doses ranging from 0.5 to 30 mg administered once a day to healthy subjects for 2 weeks produced a dose-dependent reduction in the binding of 11C-raclopride, a D2/D3 receptor ligand,
Forebyggelse af recidiv af maniske episoder ved bipolær lidelse type I: Til forebyggelse af recidiv af maniske episoder hos patienter, der har været behandlet med aripiprazol (monoterapi eller kombinationsbehandling), fortsættes behandlingen med samme dosis.
Recurrence prevention of manic episodes in Bipolar I Disorder For preventing recurrence of manic episodes in patients who have been receiving aripiprazole as monotherapy or combination therapy, continue therapy at the same dose.
Grand mal-kramper Serotoninsyndrom Taleforstyrrelser
Neuroleptic Malignant Syndrome (NMS) Grand mal convulsion Serotonin syndrome Speech disorder
4.2) Aripiprazols virkning blev undersøgt hos pædiatriske patienter med Tourettes syndrom (aripiprazol: n = 99, placebo: n = 44) i et randomiseret, dobbeltblindet, placebokontrolleret 8ugers studie med et vægtbaseret fastdosisdesign inden for et dosisområde på 5-20 mg/dag med en startdosis på 2 mg.
Tics associated with Tourette's disorder in paediatric patients (see section 4.2) The efficacy of aripiprazole was studied in paediatric subjects with Tourette's disorder (aripiprazole: n = 99, placebo: n = 44) in a randomised, double-blind, placebo controlled, 8 week study using a fixed dose weight-based treatment group design over the dose range of 5 mg/day to 20 mg/day and a starting dose of 2 mg.
I den længerevarende 26-ugers vedligeholdelsesfase i et placebokontrolleret forsøg var forekomsten af EPS 18,2 % for aripiprazol-behandlede patienter og 15,7 % for placebo-behandlede patienter.
In the long term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2% for aripiprazole-treated patients and 15.7% for placebo-treated patients.
Indeholder lactosemonohydrat og sodium.
LIST OF EXCIPIENTS Contains lactose and sodium.
Brug af anden medicin sammen med Aripiprazole Zentiva
Other medicines and Aripiprazole Zentiva
Ved samtidig anvendelse af svage CYP3A4-hæmmere (fx diltiazem) eller CYP2D6-hæmmere (fx escitalopram) og aripiprazol kan en beskeden stigning i aripiprazol-koncentrationen i plasma forventes.
When weak inhibitors of CYP3A4 (e.g. diltiazem) or CYP2D6 (e.g. escitalopram) are used concomitantly with aripiprazole, modest increases in plasma aripiprazole concentrations may be expected.
Irritabilitet associeret med autisme: Aripiprazols sikkerhed og virkning hos børn og unge under 18 år er endnu ikke blevet klarlagt.
The safety and efficacy of aripiprazole in children and adolescents aged below 18 years have not yet been established.
Tics associeret med Tourettes syndrom hos pædiatriske patienter (se pkt.
Tics associated with Tourette's disorder
Skizofreni hos unge i alderen 15 år eller ældre: Den anbefalede dosis for Aripiprazole Zentiva er 10 mg/dag, administreret som en enkelt daglig dosis uden hensyntagen til måltider.
Schizophrenia in adolescents aged 15 years and older The recommended dose for Aripiprazole Zentiva is 10 mg/day administered on a once-a-day schedule without regard to meals.
Aripiprazole Zentiva 10 mg, 30 mg tabletter: Formålet med delekærven er ikke at kunne brække smeltetabletten over.
Aripiprazole Zentiva 10 mg, 30 mg tablets: The score line is not intended for breaking the tablet.
I et 26-ugers, kontrolleret, dobbeltblindt, multinationalt forsøg med olanzapin til behandling af skizofreni, som inkluderede 314 voksne patienter, og hvor det primære endepunkt var vægtstigning, fandtes signifikant færre patienter at have 7 % eller yderligere vægtstigning i forhold til baseline (dvs. en stigning på mindst 5,6 kg for en middel-baselinevægt på ∼80,5 kg) med aripripazol (n = 18 eller 13 % af de evaluérbare patienter) sammenlignet med olanzapin (n = 45 eller 33 % af de evaluérbare patienter).
In a 26week, olanzapine-controlled, double-blind, multi-national study of schizophrenia which included 314 adult patients and where the primary end-point was weight gain, significantly less patients had at least 7% weight gain over baseline (i.e. a gain of at least 5.6 kg for a mean baseline weight of ~80.5 kg)
• hurtig hjerterytme,
• fast heart beat,
Tegn og symptomer på denne tilstand kan især forekomme ved samtidig anvendelse af andre serotonerge lægemidler som fx SSRI/SNRI, og af lægemidler, der er kendt for at øge aripiprazol- koncentrationen (se pkt.
Cases of serotonin syndrome have been reported in patients taking aripiprazole, and possible signs and symptoms for this condition can occur especially in cases of concomitant use with other serotonergic medicinal products, such as SSRI/SNRI, or with medicinal products that are known to increase aripiprazole concentrations (see section 4.8).
Maniske episoder ved bipolær lidelse type I - i et 12-ugers, kontrolleret forsøg var forekomsten af EPS 23,5 % for aripiprazol-behandlede patienter og 53,3 % for haloperidol-behandlede patienter.
Manic episodes in Bipolar I Disorder - in a 12-week controlled trial, the incidence of EPS was 23.5% for aripiprazole-treated patients and 53.3% for haloperidol-treated patients.
I et længerevarende, 26-ugers placebo-kontrolleret forsøg var forekomsten af EPS 19 % for aripiprazol-behandlede patienter og 13,1 % for placebo-behandlede patienter.
In a long term 26-week placebo-controlled trial, the incidence of EPS was 19% for aripiprazole-treated patients and 13.1% for placebo-treated patients.
Brug af Aripiprazole Zentiva sammen med mad, drikke og alkohol
Aripiprazole Zentiva with food, drink and alcohol This medicine can be taken regardless of meals.
C-racloprid, en D2/D3-receptorligand til caudatus og putamen påvist ved positronemissionstomografi.
to the caudate and putamen detected by positron emission tomography.
Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, crospovidon, hydroxypropylcellulose, vandfri kolloid silica, croscarmellosenatirum, acesulfamkalium, mangosmag, magnesiumstearat.
The other ingredients are lactose monohydrate, microcrystalline cellulose, crospovidone, hydroxypropyl cellulose, silica colloidal anhydrous, croscarmellose sodium, acesulfame potassium, mango flavour, magnesium stearate.
• smertestillende midler (fx tramadol og pethidin) til lindring af smerter
• Pain killers (such as tramadol and pethidine) used for pain relief
I et andet længerevarende, 26-ugers kontrolleret forsøg var forekomsten af EPS 14,8 % for aripiprazol-behandlede patienter og 15,1 % for olanzapin-behandlede patienter.
In another long-term 26-week controlled trial, the incidence of EPS was 14.8% for aripiprazole-treated patients and 15.1% for olanzapine-treated patients.
Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, crospovidon, hydroxypropylcellulose, vandfri kolloid silica, croscarmellosenatirum, magnesiumstearat.
The other ingredients are lactose monohydrate, microcrystalline cellulose, crospovidone, hydroxypropyl cellulose, silica colloidal anhydrous, croscarmellose sodium, magnesium stearate.
Maniske episoder ved bipolær lidelse type I hos unge i alderen 13 år og ældre: Den anbefalede dosis af Aripiprazole Zentiva er 10 mg/dag, administreret som en enkelt daglig dosis uden hensyntagen til måltider.
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older The recommended dose for Aripiprazole Zentiva is 10 mg/day administered on a once-a-day schedule without regard to meals.
Hjælpestof, som behandleren skal være opmærksom på: Hver smeltetablet indeholder 55,5 mg lactose (som monohydrat) og 1,97 mg sodium.
Excipient with known effect: each orodispersible tablet contains 55.5 mg of lactose (as monohydrate) and 1.97 mg of sodium.
Hver tablet indeholder 5 mg/10 mg/30 mg aripiprazol.
Each tablet contains 5 mg/10 mg/15 mg/30 mg of aripiprazole.
Forekomsten af hypoprolaktinæmi eller nedsat serumprolaktin i aripiprazol-gruppen var 0,4 %, mens den var 0,02 % i placebo-gruppen.
The incidence of hypoprolactinaemia or decreased serum prolactin in patients treated with aripiprazole was 0.4%, compared with 0.02% for patients treated with placebo.
• medicin mod depression eller naturmedicin mod depression og angst (fx fluoxetin, paroxetin,
• Antidepressants or herbal remedy used to treat depression and anxiety (such as fluoxetine,
Pakningsstørrelser: 14, 28 eller 49 smeltetabletter.
Pack size: 14, 28 or 49 orodispersible tablets
Ved afbrydelse af behandling med CYP2D6- eller CYP3A4-hæmmer, bør aripiprazoldosis øges til niveauet inden start af den samtidige behandling.
Upon discontinuation of the CYP2D6 or CYP3A4 inhibitor, the dosage of aripiprazole should be increased to the level prior to the initiation of the concomitant therapy.
- uhæmmet madindtagelse (spise store mængder mad i en kort periode) eller overdreven madindtagelse (spise mere mad end sædvanligt og mere end nødvendigt for at dække sulten),
strong impulse to gamble excessively despite serious personal or family consequences altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive uncontrollable excessive shopping binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger) a tendency to wander away.
Maniske episoder ved bipolær lidelse type I: Den anbefalede startdosis for Aripiprazole Zentiva er 15 mg administreret som en enkelt daglig dosis, uden hensyntagen til måltider, som enkeltstofbehandling eller kombinationsbehandling (se pkt.
The recommended starting dose for Aripiprazole Zentiva is 15 mg administered on a once-a-day schedule without regard to meals as monotherapy or combination therapy (see section 5.1).
Der er ingen forskel på farmakokinetik for aripiprazol hos raske, ældre og yngre voksne forsøgspersoner, ligesom der i en farmakokinetisk populationsanalyse af skizofrene patienter ikke er set påviselig effekt af alder.
There are no differences in the pharmacokinetics of aripiprazole between healthy elderly and younger adult subjects, nor is there any detectable effect of age in a population pharmacokinetic analysis in schizophrenic patients.
Forhøjet blodsukker Forhøjet glykosyleret hæmoglobin Fluktuerende blodsukkerniveau Forhøjet kreatinkinase
Blood glucose fluctuation Increased creatine phosphokinase
Maniske episoder ved bipolær lidelse type I hos unge i alderen 13 år og ældre Hyppigheden og typen af bivirkninger hos unge med bipolær lidelse type I var de samme som hos voksne med undtagelse af følgende bivirkninger: meget almindelig (≥ 1/10) døsighed (23,0 %), ekstrapyramidale symptomer (18,4 %), akatisi (16,0 %) og træthed (11,8 %); og almindelig (≥ 1/100 til < 1/10) øvre abdominalsmerter, øget hjertefrekvens, vægtstigning, øget appetit, muskeltrækninger og dyskinesi.
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older The frequency and type of adverse reactions in adolescents with Bipolar I Disorder were similar to those in adults except for the following reactions: very commonly (≥ 1/10) somnolence (23.0%), extrapyramidal disorder (18.4%), akathisia (16.0%), and fatigue (11.8%); and commonly (≥ 1/100,
Crospovidon Hydroxypropylcellulose Silica, kolloid vandfri Croscarmellosenatrium Acesulfamkalium Mangosmag Magnesiumstearat
Lactose monohydrate Microcrystalline cellulose Crospovidone Hydroxypropyl cellulose Silica colloidal anhydrous Croscarmellose sodium Acesulfame potassium Mango flavour Magnesium stearate
I den poolede population af unge med skizofreni (13 - 17 år) med en eksponering i op til 2 år var incidensen af lave serum prolaktinniveauer for kvinder (< 3 ng/ml) og mænd (< 2 ng/ml) henholdsvis 29,5 % og 48,3 %.
In the pooled adolescent schizophrenia population (13 - 17 years) with exposure up to 2 years, incidence of low serum prolactin levels in females (< 3 ng/ml) and males (< 2 ng/ml) was 29.5% and 48.3%, respectively.
Åbn pakken og træk folien af blisteren for at frigøre smeltetabletten.
Immediately upon opening the blister, using dry hands, remove the tablet and place the entire orodispersible tablet on the tongue.
Hjælpestof, som behandleren skal være opmærksom på: Hver smeltetablet indeholder 111 mg lactose (som monohydrat) og 3,93 mg sodium.
Excipient with known effect: each orodispersible tablet contains 111 mg of lactose (as monohydrate) and 3.93 mg of sodium.
Hver smeltetablet indeholder 10 mg/15 mg/30 mg aripiprazol.
Each orodispersible tablet contains 10 mg/15 mg/30 mg of aripiprazole.
Aripiprazole Zentiva indeholder lactose
Aripiprazole Zentiva tablets contain lactose.
Tics associeret med Tourettes syndrom: Aripiprazols sikkerhed og virkning hos børn og unge i alderen 6-18 år er endnu ikke klarlagt.
The safety and efficacy of aripiprazole in children and adolescents 6 to 18 years of age have not yet been established.
Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 198 mg lactose (som monohydrat) og 5,62 mg sodium.
Excipient with known effect: each tablet contains 198 mg of lactose (as monohydrate) and 5.62 mg of sodium.
Hos den unge population (13 - 17 år) med skizofreni, der blev eksponeret for 5 til 30 mg aripiprazol i op til 72 måneder, var incidensen af lavt serumprolaktin hos pigerne (< 3 ng/ml) og drengene (< 2 ng/ml) henholdsvis 25,6 % og 45,0 %.
In the adolescent (13 - 17 years) schizophrenia population with aripiprazole exposure of 5 to 30 mg up to 72 months, incidence of low serum prolactin levels in females (< 3 ng/ml) and males (< 2 ng/ml) was 25.6% and 45.0%, respectively.
Oplever du uventede virkninger, mens du tager en af disse typer medicin sammen med Aripiprazole Zentiva, skal du kontakte din læge.
These medicines may increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with Aripiprazole Zentiva, you should see your doctor.
Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 33 mg lactose (som monohydrat) og 0,94 mg sodium.
Excipient with known effect: each tablet contains 33 mg of lactose (as monohydrate) and 0.94 mg of sodium.
Hydroxypropylcellulose Silica, kolloid vandfri Croscarmellosenatrium Magnesiumstearat
Lactose monohydrate Microcrystalline cellulose Crospovidone Hydroxypropyl cellulose Silica colloidal anhydrous Croscarmellose sodium Magnesium stearate
Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 99 mg lactose (som monohydrat) og 2,81 mg sodium.
Excipient with known effect: each tablet contains 99 mg of lactose (as monohydrate) and 2.81 mg of sodium.
Aripiprazole Zentiva 5 mg tabletter Aripiprazole Zentiva 10 mg tabletter Aripiprazole Zentiva 15 mg tabletter Aripiprazole Zentiva 30 mg tabletter
Aripiprazole Zentiva 5 mg tablets Aripiprazole Zentiva 10 mg tablets Aripiprazole Zentiva 15 mg tablets Aripiprazole Zentiva 30 mg tablets
I to længerevarende forsøg med unge patienter i alderen 13 - 17 år med skizofreni og bipolær lidelse, der blev behandlet med aripiprazol, var forekomsten af lavt serumprolaktin hos piger (< 3 ng/ml) og drenge (< 2 ng/ml) henholdsvis 37,0 % og 59,4 %.
In two long term trials with adolescent (13 - 17 years) schizophrenia and bipolar patients treated with aripiprazole, incidence of low serum prolactin levels in females (< 3 ng/ml) and males (< 2 ng/ml) was 37.0 % and 59.4 %, respectively.
Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 66 mg lactose (som monohydrat) og 1,87 mg sodium.
Excipient with known effect: each tablet contains 66 mg of lactose (as monohydrate) and 1.87 mg of sodium.
Aripiprazole Zentiva smeltetabletter indeholder lactose og bør ikke anvendes til patienter med arvelig galactoseintolerans, en særlig form for hereditær lactasemangel (Lapp-Lactase deficiency) eller glucose/galactose malabsorption.
Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Sådan skal du tage Aripiprazole Zentiva
How to take Aripiprazole Zentiva
Ved samtidig administration af ketoconazol og aripiprazol bør aripiprazoldosis halveres.
When concomitant administration of ketoconazole with aripiprazole occurs, aripiprazole dose should be reduced to approximately one-half of its prescribed dose.
Hjælpestof, som behandleren skal være opmærksom på: Hver smeltetablet indeholder 37 mg lactose (som monohydrat) og 1,31 mg sodium.
Excipient with known effect: each orodispersible tablet contains 37 mg of lactose (as monohydrate) and 1.31 mg of sodium.
NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN
NAME OF THE MARKETING AUTHORISATION HOLDER Zentiva logo
Det betyder ikke noget om du tager dem sammen med et måltid eller ej. Tabletterne skal altid tages med et glas vand og synkes hele.
Always take the tablet with water and swallow it whole.
Aripiprazole Zentiva 5 mg tabletter Aripiprazole Zentiva 10 mg tabletter Aripiprazole Zentiva 15 mg tabletter Aripiprazole Zentiva 30 mg tabletter aripiprazol
Aripiprazole Zentiva 5 mg tablets Aripiprazole Zentiva 10 mg tablets Aripiprazole Zentiva 15 mg tablets Aripiprazole Zentiva 30 mg tablets aripiprazole
Hvide til råhvide runde tabletter uden overtræk, præget på den ene side med '10' og snap tab delekærv på den anden side, ca. 8 mm i diameter.
White to off-white round uncoated tablets with ‘10' debossed on one side and snap tab breakline on the other side with diameter approx. 8 mm.
I et randomiseret, dobbeltblindet, placebokontrolleret 10-ugers studie gennemført i Sydkorea blev aripiprazols virkning hos pædiatriske patienter med Tourettes syndrom (aripiprazol: n = 32, placebo: n = 29) undersøgt inden for et fleksibelt dosisområde på 2-20 mg/dag med en startdosis på 2 mg.
The efficacy of aripiprazole in paediatric subjects with Tourette's syndrome (aripiprazole: n = 32, placebo: n = 29) was also evaluated over a flexible dose range of 2 mg/day to 20 mg/day and a starting dose of 2 mg, in a 10 week, randomised, double blind, placebo-controlled study conducted in SouthKorea.
Aripiprazole Zentiva 10 mg tabletter
Aripiprazole Zentiva 10 mg tablets
Aripiprazole Zentiva 30 mg tabletter EU/1/15/1009/016
Aripiprazole Zentiva 30 mg tablets EU/1/15/1009/016